REGENERON PHARMACEUTICALS, INC. (REGN) Corporate Subsidiaries
REGENERON PHARMACEUTICALS, INC. (REGN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: REGN
CIK: 872589
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NY
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSonia Luaces
Audit LocationFlorham Park, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-13 | PRIMARY DOCUMENT | 0001796226-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001969223-26-001073 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-01 | FORM 8-K | 0001104659-26-113895 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-24 | FORM 8-K | 0001104659-26-112340 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | PRIMARY DOCUMENT | 0001663758-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | PRIMARY DOCUMENT | 0001992352-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001969223-26-000991 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001969223-26-000988 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001969223-26-000987 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | PRIMARY DOCUMENT | 0001238303-26-000002 | View SEC Doc Filr Page |
| N-PX | 2026-08-20 | 2026-06-30 | N-PX Filing | 0001104659-26-099230 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | PRIMARY DOCUMENT | 0001697422-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | PRIMARY DOCUMENT | 0001992352-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | PRIMARY DOCUMENT | 0001681643-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001969223-26-000871 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001969223-26-000870 | View SEC Doc Filr Page |
| 13F-HR | 2026-08-07 | 2026-06-30 | 13F-HR Filing | 0001104659-26-092709 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0000872589-26-000025 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0000872589-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | PRIMARY DOCUMENT | 0001187443-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-06 | FORM 8-K | 0001104659-26-080562 | View SEC Doc Filr Page |
| 144 | 2026-07-02 | — | 144 Filing | 0001968582-26-000693 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-12 | FORM 8-K | 0001104659-26-075127 | View SEC Doc Filr Page |
| 13F-HR | 2026-05-08 | 2026-03-31 | 13F-HR Filing | 0001104659-26-057922 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001187443-26-000008 | View SEC Doc Filr Page |